Responses to glycemic control therapy according to age, gender, level of adiposity, and duration of diabetes in type 2 diabetic patients

Indian Journal of Medical Sciences

Volumn 67, Issue 3, 2013, Pages 61-69

  Ewenighi, Chinwe O ^a   Uchechukwu, Dimkpa ^b   Adejumo, Babatunde I ^c   Onyeanusi, J C ^a   Nnatuanya, I N ^a   Onoh, O Gladys ^a   Okorie, C Eze ^d   Ogbuike, O Ibeagi ^d  

^a EBONYI STATE UNIVERSITY   (Nigeria)

^b NNAMDI AZIKIWE UNIVERSITY   (Nigeria)

^c UNIVERSITY OF BENIN   (Nigeria)

^d FEDERAL TEACHING HOSPITAL   (Nigeria)

Author keywords

Diabetes mellitus; Diet therapy; Drug compliance; Glycemic control; Metformin; Type 2 diabetes

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C; METFORMIN;

ADULT; AGE; AGED; ARTICLE; BODY MASS; CLINICAL DECISION MAKING; DIABETIC PATIENT; DIET THERAPY; DISEASE DURATION; DRUG DOSE INCREASE; DRUG WITHDRAWAL; EXERCISE; FEMALE; GENDER; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HEMOGLOBIN BLOOD LEVEL; HIGH FIBER DIET; HUMAN; HYPOGLYCEMIA; LIFESTYLE MODIFICATION; LOW CALORY DIET; MAJOR CLINICAL STUDY; MALE; MEDICATION COMPLIANCE; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PRESCRIPTION; SEX DIFFERENCE; SMOKING; TREATMENT RESPONSE; WEIGHT REDUCTION;

ADULT; AGE FACTORS; CALORIC RESTRICTION; COMBINED MODALITY THERAPY; DIABETES MELLITUS, TYPE 2; DIETARY FIBER; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPOGLYCEMIC AGENTS; MALE; METFORMIN; MIDDLE AGED; OBESITY; SEX FACTORS; TIME FACTORS;

EID: 84888626103     PISSN: 00195359     EISSN: 19983654     Source Type: Journal    
DOI: 10.4103/0019-5359.121117     Document Type: Article

References (33)

1. World Health Organization; Diabetes; Fact sheets N-312, January 2011.
2. National Diabetes Statistics, 2011. Complications of diabetes in the US: Heart disease and stroke. Available from: http://diabetes.niddk.nih.gov/dm/pubs/ statistics). (Last assessed on May 02, 2011).
3. Klein R. Hyperglycemia and microvascular and macrovascular disease in diabetes. Diabetes Care 1995;18:258-68.
4. Adler AI, Boyko EJ, Ahroni AJ, Stensel V, Forsberg RC, Smith DG. Risk factors for diabetic peripheral sensory neuropathy. Results of the Seattle prospective diabetic foot study. Diabetes Care 1997;20:1162-7.
5. UKPDS Group. Risk factors for coronary artery disease in non-insulin dependent diabetes mellitus: United Kingdom Prospective Diabetes study (UKPDS: 23). BMJ 1998;316:823-8.
6. Kuusisto J, Mykkänen L, Pyörälä K, Laakso M. NIDDM and its metabolic control predict coronary heart disease in elderly subjects. Diabetes 1994;43:960-7.
7. Lehto S, Ronnemaa T, Pyörälä K, Laakso M. Predictors of stroke in middleaged patients with non-insulin-dependent diabetes. Stroke 1996;27:63-8.
8. Groeneveld Y, Petri H, Hermans J, Springer MP. Relationship between blood glucose level and mortality in type 2 diabetes mellitus: A systematic review. Diabet Med 1999;116:2-13.
9. Wei M, Gaskill SP, Haffner SM, Stern MP. Effects of diabetes and level of glycemia on all-cause and cardiovascular mortality. The San Antonio Heart Study. Diabetes Care 1998; 21:1167-72.
10. Effect of intensive blood glucose control with metformin on complication in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group. Lancet 1998;352:854-65.
11. Lee VW, Leung PY. Glycemic control and medication compliance in diabetic patients in a pharmacist-managed clinic in Hong Kong. Am J of Health-Syst Pharm 2003;60:2593-6.
12. Schectman JM, Nadkarni MM, Voss JD. The association between diabetes metabolic control and drug adherence in an indigent population. Diabetes Care 2002;25:1015-21.
13. DeFronzo RA, Goodman AM. Efficacy of metformin in patients with non-insulin-dependent diabetes mellitus. The Multicenter Metformin Study Group. N Engl J Med 1995;333:541-9.
14. Odegard PS, Setter SM, Neumiller JJ. Considerations for the pharmacological treatment of diabetes in older adults. Diabetes Spectrum 2007;20:239-47.
15. Mangoni AA, Jackson SH. Age-related changes in pharmacokinetics and pharmacodynamics: Basic principles and practical applications. Br J Clin Pharmacol 2004;57:6-14.
16. McLean AJ, LeCouteur DG. Aging biology and geriatrics clinical pharmacology. Pharmacol Rev 2004;56:163-84.
17. DeFronzo RA, Bonadonna RC, Ferrannini E. Pathogenesis of NIDDM: A balanced overview. Diabetes Care 1992;15:318-68.
18. Meneilly GS, Elahi D, Minaker KL, Sclater AL, Rowe JW. Impairment of noninsulin-mediated glucose disposal in the elderly. J Clin Endocrinol Metab 1989;68:566-71.
19. Reaven GM. Does age affect glucose tolerance?. Geriatrics 1977;32:51-4.
20. Nobili V, Carter-Kent C, Feldstein AE. Role of lifestyle changes in the management of chronic liver diseases. BMC Med 2011;9:70.
21. Festi D, Colecchia A, Sacco T, Bondi M, Roda E, Marchesini G. Hepatic steatosis in obese patients: Clinical aspects and prognostic significance. Obesity Rev 2004;5:27-42.
22. Hickman IJ, Powell EE, Prins JB, Clouston AD, Ash S, Purdie DM, et al. In overweight patients with chronic hepatitis C, circulating insulin is associated with hepatic fibrosis: Implications for therapy. J Hepatol 2003;39:1042-8.
23. Donnelly LA, Doney AS, Hattersley AT, Morris AD, Pearson ER. The effect of obesity on glycaemic response to metformin or sulphonylureas in Type 2 diabetes. Diabet Med 2006;23:128-33.
24. Adinolfi LE, Gambardella M, Andreana A, Tripodi MF, Utili R, Ruggiero G. Steatosis accelerates the progression of liver damage of chronic hepatitis C patients and correlates with specific HCV genotype and visceral obesity. Hepatology 2001;33:1358-64.
25. Yuan JM, Govindarajan S, Arakawa K, Yu MC. Synergism of alcohol, diabetes, and viral hepatitis on the risk of hepatocellular carcinoma in blacks and whites in the U.S. Cancer 2004;101:1009-17.
26. Yu MC, Tong MJ, Govindarajan S, Henderson BE. Non-viral risk factors for hepatocellular carcinoma in a low-risk population, the non-Asians of Los Angeles County, California. J Natl Cancer Inst 1991;83:1820-6.
27. El-Serag HB, Tran T, Everhart JE. Diabetes increases the risk of chronic liver disease and hepatocellular carcinoma. Gastroenterology 2004;126:460-8.
28. Nothwehr F, Stump T. Health-promoting behaviors among adults with type 2 diabetes: Findings from the Health and Retirement Study. Prev Med 2000;30:407-14.
29. Brooks RJ, Roxburgh S. Gender differences in the effect of the subjective experience of diabetes and sense of control on distress. Health 1999; 3:399-420.
30. Sanden-Eriksson B. Type 2 diabetes: Symptoms and impact on daily life: An eight year follow-up study of psychosocial situation and disease development. Pract Diabetes Int 2000;17:127-32.
31. Jonsson PM, Sterky G, Gafvels C, Ostman J. Gender equity in health care: The case of Swedish diabetes care. Health Care Women Int 2000;21:413-1.
32. Jonsson PM. Diabetes Mellitus, Socioeconomy and Self-Rated Health. Population-Based Studies in Cohorts Registered in the Diabetes Incidence Study in Sweden. Stockholm, Sweden, Division of International Health (IHCAR), Department of Public Health Sciences, Karolinska Institute, 2001.
33. Nielsen AB, De fine Olivarius N, Gannik D, Hindsberger C, Hollnagel H. Structured personal diabetes care in primary health care affects women's HbA1c. Diabetes Care 2006;29:963-9.